
- 积分
- 42
- 威望
- 42
- 包包
- 486
|
本帖最后由 aaaszw 于 2016-12-9 09:16 编辑 ) A1 _5 A4 j* l7 l; n6 B) z
# |, K2 T5 s+ u. a6 h4 q$ @- W- fTumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.) {( ~# ^) S; ]8 O: {& d& @/ V
https://www.ncbi.nlm.nih.gov/pubmed/27912061/ Z; B* A* K* [3 d; X
0 M: W+ O' q' }The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.5 @9 V% r+ C4 Q/ Z6 a$ s/ z5 d
https://www.ncbi.nlm.nih.gov/pubmed/27525555
! ?- U, N$ J' I5 @9 ]& z: t' u2 S, B3 ~2 z* [/ B
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion7 d2 ~! ^* O, Z0 T8 y2 [8 n
https://www.ncbi.nlm.nih.gov/pubmed/27496729
4 Z# o# y& F+ q( V9 ^0 \7 t5 Q5 i' x& Z/ W5 Y3 V& [ ~
Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.2 W, h! V' d7 c: `4 V% @
https://www.ncbi.nlm.nih.gov/pubmed/27430722
5 v6 T5 A+ g- P/ @ e, [7 d
: w4 a* ?) r: { ZCostimulatory and Coinhibitory Receptor Pathways in Infectious Disease.
- J. v' Y( C/ `5 \7 ^ {https://www.ncbi.nlm.nih.gov/pubmed/27192569
, U1 G$ |. t' ]' ]
' C( v) N# a! Y$ }! GCombination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
s9 F8 o, ?0 \6 Khttps://www.ncbi.nlm.nih.gov/pubmed/27058661
7 b, _) n& N$ }$ o
7 j4 k7 D$ P$ M" o" @/ nDe-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute/ y3 M |" F! ?6 C
https://www.ncbi.nlm.nih.gov/pubmed/27036972 |
|